Natural orifice surgery: Initial US experience utilizing the StomaphyX TM device to reduce gastric pouches after Roux-en-Y gastric bypass

Dean Mikami, Bradley Needleman, Vimal Narula, Janice Durant, W. Scott Melvin

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Introduction: Weight gain after gastric bypass can occur in up to 10% of patients 5 years following and in about 20% of patients 10 years following surgery. The nadir weight is usually reached within the first 2 years after bypass surgery. However, weight may slowly be regained for numerous reasons. This phenomenon has been studied extensively, but there is often no one reason this occurs. Once psychological and dietary reasons have been investigated, revisional surgery may be the only alternative for treatment. Revisional gastric bypass surgery is associated with a much higher morbidity and mortality when compared with a primary gastric bypass procedure. Patients and methods: Thirty-nine patients underwent endoluminal gastric pouch reduction with the StomaphyXTM device after informed consent. The StomaphyXTM device is a sterile, single-use device for use in endoluminal transoral tissue approximation and ligation in the gastrointestinal (GI) tract. Results: Average age was 47.8 (29-64) years, and 36/39 (92.3%) patients were female. Average body mass index (BMI) and weight prior to the StomaphyXTM procedure were 39.8 (22.7-63.2) kg/m2 and 108.0 kg (65.90-172.2 kg). The average preprocedure excess body weight was 51.1 kg. Weight loss at 2 weeks (n = 39) was 3.8 kg (7.4% excess body weight loss, EBWL), at 1 month (n = 34) was 5.4 kg (10.6% EBWL), at 2 months (n = 26) was 6.7 kg (13.1% EBWL), at 3 months (n = 15) was 6.7 kg (13.1% EBWL), at 6 months (n = 14) was 8.7 kg (17.0% EBWL), and at 1 year (n = 6) was 10.0 kg (19.5% EBWL). No major complications were observed. The minor complications that were seen included a sore throat lasting less than 48 h in 34/39 patients (87.1%) and epigastric pain that lasted for a few days in 30/39 patients (76.9%). Three patients with chronic diarrhea had their symptoms resolved after the procedure. Eight patients with gastroesophageal reflux disease reported improvement in their symptoms post procedure. Conclusions: Endoluminal revision of gastric bypass patients with weight gain using the StomaphyXTM procedure may offer an alternative to open or laparoscopic revisional bariatric surgery.

Original languageEnglish (US)
Pages (from-to)223-228
Number of pages6
JournalSurgical Endoscopy and Other Interventional Techniques
Volume24
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Gastric Bypass
Stomach
Equipment and Supplies
Weight Loss
Body Weight
Weights and Measures
Weight Gain
Bariatric Surgery
Pharyngitis
Gastroesophageal Reflux
Informed Consent
Ligation
Gastrointestinal Tract
Diarrhea
Body Mass Index
Psychology
Morbidity
Pain

Keywords

  • Bariatric
  • Endoluminal
  • Gastric bypass
  • Gastric pouch reduction
  • Revision
  • Weight gain

ASJC Scopus subject areas

  • Surgery

Cite this

Natural orifice surgery : Initial US experience utilizing the StomaphyX TM device to reduce gastric pouches after Roux-en-Y gastric bypass. / Mikami, Dean; Needleman, Bradley; Narula, Vimal; Durant, Janice; Melvin, W. Scott.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 24, No. 1, 01.2010, p. 223-228.

Research output: Contribution to journalArticle

@article{bf41818a52344931b212c372ba0ef2db,
title = "Natural orifice surgery: Initial US experience utilizing the StomaphyX TM device to reduce gastric pouches after Roux-en-Y gastric bypass",
abstract = "Introduction: Weight gain after gastric bypass can occur in up to 10{\%} of patients 5 years following and in about 20{\%} of patients 10 years following surgery. The nadir weight is usually reached within the first 2 years after bypass surgery. However, weight may slowly be regained for numerous reasons. This phenomenon has been studied extensively, but there is often no one reason this occurs. Once psychological and dietary reasons have been investigated, revisional surgery may be the only alternative for treatment. Revisional gastric bypass surgery is associated with a much higher morbidity and mortality when compared with a primary gastric bypass procedure. Patients and methods: Thirty-nine patients underwent endoluminal gastric pouch reduction with the StomaphyXTM device after informed consent. The StomaphyXTM device is a sterile, single-use device for use in endoluminal transoral tissue approximation and ligation in the gastrointestinal (GI) tract. Results: Average age was 47.8 (29-64) years, and 36/39 (92.3{\%}) patients were female. Average body mass index (BMI) and weight prior to the StomaphyXTM procedure were 39.8 (22.7-63.2) kg/m2 and 108.0 kg (65.90-172.2 kg). The average preprocedure excess body weight was 51.1 kg. Weight loss at 2 weeks (n = 39) was 3.8 kg (7.4{\%} excess body weight loss, EBWL), at 1 month (n = 34) was 5.4 kg (10.6{\%} EBWL), at 2 months (n = 26) was 6.7 kg (13.1{\%} EBWL), at 3 months (n = 15) was 6.7 kg (13.1{\%} EBWL), at 6 months (n = 14) was 8.7 kg (17.0{\%} EBWL), and at 1 year (n = 6) was 10.0 kg (19.5{\%} EBWL). No major complications were observed. The minor complications that were seen included a sore throat lasting less than 48 h in 34/39 patients (87.1{\%}) and epigastric pain that lasted for a few days in 30/39 patients (76.9{\%}). Three patients with chronic diarrhea had their symptoms resolved after the procedure. Eight patients with gastroesophageal reflux disease reported improvement in their symptoms post procedure. Conclusions: Endoluminal revision of gastric bypass patients with weight gain using the StomaphyXTM procedure may offer an alternative to open or laparoscopic revisional bariatric surgery.",
keywords = "Bariatric, Endoluminal, Gastric bypass, Gastric pouch reduction, Revision, Weight gain",
author = "Dean Mikami and Bradley Needleman and Vimal Narula and Janice Durant and Melvin, {W. Scott}",
year = "2010",
month = "1",
doi = "10.1007/s00464-009-0640-y",
language = "English (US)",
volume = "24",
pages = "223--228",
journal = "Surgical Endoscopy and Other Interventional Techniques",
issn = "0930-2794",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Natural orifice surgery

T2 - Initial US experience utilizing the StomaphyX TM device to reduce gastric pouches after Roux-en-Y gastric bypass

AU - Mikami, Dean

AU - Needleman, Bradley

AU - Narula, Vimal

AU - Durant, Janice

AU - Melvin, W. Scott

PY - 2010/1

Y1 - 2010/1

N2 - Introduction: Weight gain after gastric bypass can occur in up to 10% of patients 5 years following and in about 20% of patients 10 years following surgery. The nadir weight is usually reached within the first 2 years after bypass surgery. However, weight may slowly be regained for numerous reasons. This phenomenon has been studied extensively, but there is often no one reason this occurs. Once psychological and dietary reasons have been investigated, revisional surgery may be the only alternative for treatment. Revisional gastric bypass surgery is associated with a much higher morbidity and mortality when compared with a primary gastric bypass procedure. Patients and methods: Thirty-nine patients underwent endoluminal gastric pouch reduction with the StomaphyXTM device after informed consent. The StomaphyXTM device is a sterile, single-use device for use in endoluminal transoral tissue approximation and ligation in the gastrointestinal (GI) tract. Results: Average age was 47.8 (29-64) years, and 36/39 (92.3%) patients were female. Average body mass index (BMI) and weight prior to the StomaphyXTM procedure were 39.8 (22.7-63.2) kg/m2 and 108.0 kg (65.90-172.2 kg). The average preprocedure excess body weight was 51.1 kg. Weight loss at 2 weeks (n = 39) was 3.8 kg (7.4% excess body weight loss, EBWL), at 1 month (n = 34) was 5.4 kg (10.6% EBWL), at 2 months (n = 26) was 6.7 kg (13.1% EBWL), at 3 months (n = 15) was 6.7 kg (13.1% EBWL), at 6 months (n = 14) was 8.7 kg (17.0% EBWL), and at 1 year (n = 6) was 10.0 kg (19.5% EBWL). No major complications were observed. The minor complications that were seen included a sore throat lasting less than 48 h in 34/39 patients (87.1%) and epigastric pain that lasted for a few days in 30/39 patients (76.9%). Three patients with chronic diarrhea had their symptoms resolved after the procedure. Eight patients with gastroesophageal reflux disease reported improvement in their symptoms post procedure. Conclusions: Endoluminal revision of gastric bypass patients with weight gain using the StomaphyXTM procedure may offer an alternative to open or laparoscopic revisional bariatric surgery.

AB - Introduction: Weight gain after gastric bypass can occur in up to 10% of patients 5 years following and in about 20% of patients 10 years following surgery. The nadir weight is usually reached within the first 2 years after bypass surgery. However, weight may slowly be regained for numerous reasons. This phenomenon has been studied extensively, but there is often no one reason this occurs. Once psychological and dietary reasons have been investigated, revisional surgery may be the only alternative for treatment. Revisional gastric bypass surgery is associated with a much higher morbidity and mortality when compared with a primary gastric bypass procedure. Patients and methods: Thirty-nine patients underwent endoluminal gastric pouch reduction with the StomaphyXTM device after informed consent. The StomaphyXTM device is a sterile, single-use device for use in endoluminal transoral tissue approximation and ligation in the gastrointestinal (GI) tract. Results: Average age was 47.8 (29-64) years, and 36/39 (92.3%) patients were female. Average body mass index (BMI) and weight prior to the StomaphyXTM procedure were 39.8 (22.7-63.2) kg/m2 and 108.0 kg (65.90-172.2 kg). The average preprocedure excess body weight was 51.1 kg. Weight loss at 2 weeks (n = 39) was 3.8 kg (7.4% excess body weight loss, EBWL), at 1 month (n = 34) was 5.4 kg (10.6% EBWL), at 2 months (n = 26) was 6.7 kg (13.1% EBWL), at 3 months (n = 15) was 6.7 kg (13.1% EBWL), at 6 months (n = 14) was 8.7 kg (17.0% EBWL), and at 1 year (n = 6) was 10.0 kg (19.5% EBWL). No major complications were observed. The minor complications that were seen included a sore throat lasting less than 48 h in 34/39 patients (87.1%) and epigastric pain that lasted for a few days in 30/39 patients (76.9%). Three patients with chronic diarrhea had their symptoms resolved after the procedure. Eight patients with gastroesophageal reflux disease reported improvement in their symptoms post procedure. Conclusions: Endoluminal revision of gastric bypass patients with weight gain using the StomaphyXTM procedure may offer an alternative to open or laparoscopic revisional bariatric surgery.

KW - Bariatric

KW - Endoluminal

KW - Gastric bypass

KW - Gastric pouch reduction

KW - Revision

KW - Weight gain

UR - http://www.scopus.com/inward/record.url?scp=74149086306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74149086306&partnerID=8YFLogxK

U2 - 10.1007/s00464-009-0640-y

DO - 10.1007/s00464-009-0640-y

M3 - Article

C2 - 19633885

AN - SCOPUS:74149086306

VL - 24

SP - 223

EP - 228

JO - Surgical Endoscopy and Other Interventional Techniques

JF - Surgical Endoscopy and Other Interventional Techniques

SN - 0930-2794

IS - 1

ER -